GPs are being urged to ramp up diabetes treatment within just three months if they do not reach their glycaemic goals on metformin alone, under a radical update of guidelines issued by European and American diabetes societies. The new approach would advise GPs read more »

New guidance from NICE includes a particular focuses on those from black, ethnic minority or lower socio-economic groups, which are at greater risk of developing diabetes.Under the guidance, GPs will be asked to work with local health and social professionals to develop read more »

NICE has issued its Final Appraisal Determination (FAD) on the use of Victoza (liraglutide) for people with type 2 diabetes in the UK, the only therapy of its kind due to receive statutory funding direction. Liraglutide is a once-daily injectable human GLP-1 read more »